The clinical symptoms of Parkinson's disease.

Sveinbjornsdottir, Sigurlaug·2016·Journal of Neurochemistry

Cited by (1,401)

Items 901–1,000 of 1,401

  1. Hybrid Approach for Parkinson’s Disease Detection: Integrating Handcrafted and Deep Features from Handwriting Analysis Using a Voting Classifier
    DhiaEddine Aridhi, Imen Hamrouni Trimech, Najoua Essoukri Ben Amara · 2025 · International Conference on Control, Decision and Information Technologies (CoDIT)
  2. Astrocytic lysosome deficits reduce alpha-synuclein degradation and induce the spread of pathology
    Lindsay M. Roth, Olga Morozova, Jan Stöhr, Jason Schapansky · 2026 · Neurobiology of Disease
  3. Anti-Inflammatory and Neuroprotective Effects of a Novel Water-Soluble Formulation of Coenzyme-Q10 and Ashwagandha Root Extract in a Paraquat-Induced Rat Model of Parkinson’s Disease
    Caleb Vegh, Gabrielle Walach, Keanna Dube, Natasha Jaleh Malakoti-Negad, Darcy Wear, Hasana Jayawardena, Mansi B. Patel, Alexa Polsinelli, Şeyma Eren, Jerome S. Cohen et al. · 2026 · Biomedicine Hub
  4. Gait analysis and severity rating of Parkinson’s disease based on pressure and inertial sensors
    Miaoxin Ji, Renhao Ren, Qiangwei Xu · 2026 · Biomedical Signal Processing and Control
  5. Effects of neuromelanin buildup in rodent nigral dopamine neurons: implications for sex-biased vulnerability in Parkinson's disease
    Sebastian Luca D'Addario, Mariangela Massaro Cenere, Francesca Cossa et al. · 2026 · Neurobiology of Disease
  6. A New E-Health Tool for Early Identification of Voice and Neurological Pathologies by Speech Processing
    Lamia Bouafif, Noureddine Ellouze · 2018 · International Journal of Advanced Computer Science and Applications
  7. How far can I reach? The perception of upper body action capabilities in Parkinson’s disease
    Megan Rose Readman, Neil M. McLatchie, Ellen Poliakoff, Trevor J. Crawford, Sally A. Linkenauger · 2021 · Attention Perception & Psychophysics
  8. Parkinson’s Disease Diagnostics. Part 2. Structural Neuroimaging
    Сапронова Маргарита Рафаильевна, Krasnoyarsk, Russian Federation, Д. В. Дмитренко · 2021 · Doctor Ru
  9. Evaluation of Sleep Disorders in Parkinson’s Diseases and Correlation of the Risk Factors with Anxiety
    Ayesha Aslam, Naeem Amjad, Meer Wasiq Wasiq, Nauman Mazhar, Ikram ul Haq, Mubashir Ahmed · 2022 · Life and Science
  10. Partner perception of affective, behavioral, and cognitive reactions to voice use in people with Parkinson’s disease
    Zoë Thijs, Yan Zhang, Kristiane M. Van Lierde, Martine Vanryckeghem, Christopher R. Watts · 2022 · Clinical Parkinsonism & Related Disorders
  11. Intergenerational choral singing to improve communication outcomes in Parkinson’s disease: Development of a theoretical framework and an integrated measurement tool
    Panying Rong, Julia Benson · 2022 · International Journal of Speech-Language Pathology
  12. Influence of Rhythmic Auditory Stimulation using music associated with physical therapy on depressive symptoms in Parkinson’s
    Cleysiane de Araújo Oliveira, Ihana Thaí­s Guerra de Oliveira Gondim, Izaura Muniz Azevedo, Cilene Rejane Ramos Alves, Nadja Maria Jorge Asano, Maria das Graças Wanderley de Sales Coriolano · 2022 · Fisioterapia e Pesquisa
  13. The effect of rehabilitation in a virtual reality environment on improving balance in older adults with Parkinsons disease: A systematic review
    Christos Mylonas, Paris Iakovidis, Anastasios Kottaras, Dimitrios Lytras, Konstantinos Kasimis, Antonis Fetlis · 2023 · National Journal of Clinical Orthopaedics
  14. Detection of Parkinson's Disease Using Support Vector Machine and Combination of Various Tissue Density Features
    Reema Ganotra, Shailender Gupta · 2023 · Lecture notes in electrical engineering
  15. Linking Data Collected from Mobile Phones with Symptoms Level in Parkinson’s Disease: Data Exploration of the mPower Study
    Gent Ymeri, Dario Salvi, Carl Magnus Olsson · 2023 · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering
  16. Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury
    Lianyuan Feng, Aruna Sharma, Zhenguo Wang, Dafin Fior Muresanu, Z. Ryan Tian, José Vicente Lafuente, Anca Dana Buzoianu, Ala Nozari, Lars Wiklund, Hari Shanker Sharma · 2023 · Advances in neurobiology
  17. Evaluation of Nocturnal Symptoms in Chinese Parkinson’s Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study
    Wen Su, Pei Huang, Xinxin Ma, Huifang Shang, Qinyong Ye, Oumei Cheng, Piu Chan, Chun‐Feng Liu, Weiguo Liu, Beisha Tang et al. · 2023 · Journal of Parkinson s Disease
  18. Physiotherapy Approach to a Stage V Parkinson’s Disease Patient: A Case Report
    Shruti S Bhoge, Pallavi Harjpal, Ruta Gupta · 2023 · Cureus
  19. Parkinson’s disease diagnostics using ai and natural language knowledge transfer
    Maurycy Chronowski, Maciej Kłaczyński, Małgorzata Dec‐Ćwiek, Karolina Porębska · 2023 · Diagnostyka
  20. New insights in non-motor symptoms in Parkinson’s disease
    Cristian Falup‐Pecurariu, Alessandra Fanciulli, Rupam Borgohain, К. Ray Chaudhuri, Vinod Metta · 2024 · Frontiers research topics
  21. Limb and joint kinetics during walking in individuals with Mild-Moderate Parkinson’s disease
    Emily M Hayworth, Stephanie M Casnave, Chelsea Duppen · 2024 · Journal of Biomechanics
  22. Dose-Ranging Effects of the Intracerebral Administration of Atsttrin in Experimental Model of Parkinson’s Disease Induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Mice
    Łukasz A. Poniatowski, Ilona Joniec‐Maciejak, Adriana Wawer, Anna Sznejder-Pachołek, Ewa Machaj, Katarzyna Ziętal, Dagmara Maria Mirowska-Guzel · 2024 · Molecular Neurobiology
  23. Detection and Suppression of Parkinson's Disease Tremors
    Unnati Seshadri · 2023 · IEEE MIT Undergraduate Research Technology Conference (URTC)
  24. Moving Beyond Medication: Harnessing the Power of Physical Therapy and Dance Therapy in Parkinson's Disease Management
    Ksawery Adamiec, Dominik Trojanowski, Małgorzata Rodak · 2024 · Quality in Sport
  25. Intelligent Parkinson’s Disease Detection: Optimization Algorithm Implementation for SVM and MLP Classifiers on Voice Bio-Markers
    Panduranga Vital Terlapu, M. Naga Swetha, Julia Ram · 2024 · Advances in computer science research
  26. Alteraciones de la voz y habla en la enfermedad de Parkinson: Una revisión de la literatura
    Gerson Jara Cabrera, Patricia-Guadalupe Farías · 2023 · REVISTA CIENTÍFICA SIGNOS FÓNICOS
  27. Health Service Improvement for People with Parkinson’s Disease: A Scoping Review
    Susan Schneider Williams, Sarah Jane Prior · 2024 · Journal of Ageing and Longevity
  28. Innovative Detection and Segmentation of Mobility Activities in Patients Living with Parkinson’s Disease Using a Single Ankle-Positioned Smartwatch
    Étienne Goubault, Christian Duval, Camille Martin, Karina Lebel · 2024 · Sensors
  29. Parkinson’s disease classification and prediction via adaptive sparse learning from multiple modalities
    Zhongwei Huang, Jianqiang Li, Jiatao Yang, Jun Wan, Jianxia Chen, Zhi Xiang Yang, Ming Shi, Ran Zhou, Haitao Gan · 2024 · Biomedical Signal Processing and Control
  30. LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation
    Yuqi Liu, Dan Feng, Fenfen Liu · 2024 · Gerontology
  31. Exploring Mitochondrial Quality in Aging and Neurodegenerative Diseases
    Xin Jiao, Meiyu Li, Donghui Na, Meng Meng, Guohui Zhang, Ying Guo · 2024 · Neurochemical Journal
  32. Spirituality, Spiritual Distress and Experiences of Joy, Meaning and Growth Among Parkinson’s Disease Caregivers in the United States
    Sandhya Seshadri, Angela Contento, Sue E. Ouellette, Kei Sugiura, Benzi M. Kluger · 2024 · Journal of Religion and Health
  33. Associations of motor and neuropsychiatric symptoms with comorbidities in prodromal Parkinson’s disease
    Jia-Ru Chen, Yan Ping Sun, Ya‐Hui Ma, Lan Tan · 2024 · Frontiers in Aging Neuroscience
  34. Drug-induced parkinsonism in a patient with DiGeorge syndrome: a case report
    Clancy Cerejo, Nicolas De Cleene, Gerald Walser · 2024 · Frontiers in Neuroscience
  35. Review of Parkinson’s disease detection with deep‑learning machines
    Ali Abdulameer Aldujaili, Manuel Rosa-Zurera, Manuel Utrilla-Manso · 2024 · Multimedia Tools and Applications
  36. Machine Learning and Statistical Analyses of Sensor Data Reveal Variability Between Repeated Trials in Parkinson’s Disease Mobility Assessments
    Rana M. Khalil, Lisa M. Shulman, Ann L. Gruber‐Baldini, Sunita Shakya, Jeffrey M. Hausdorff, Rainer von Coelln, Michael P. Cummings · 2024 · Sensors
  37. Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease
    Noemi Pisani, Michela Russo, Maria Consiglia Calabrese · 2024 · IEEE International Conference on Metrology for eXtended Reality, Artificial Intelligence and Neural Engineering (MetroXRAINE)
  38. Associations of Dietary Intakes with Parkinson’s Disease: Findings from a Cross-Sectional Study
    Zhaohao Zeng, Lijiao Xiong, Yanmei Cen, Guo Hong, Yingao Shen, Xiaoguang Luo · 2024 · International Journal for Vitamin and Nutrition Research
  39. Chalcones As Modulators Of Neurodegenerative Processes: Exploring Their Role In Alzheimer's And Parkinson's Diseases
    Nashwa K.K, Kumari Anuja · 2024 · International Journal of Allied Medical Sciences and Clinical Research
  40. Using Healthcare Redesign to Identify Medication Management Issues in Parkinson’s Disease
    Susan Williams, Marissa A. Iannuzzi, Sarah Jane Prior · 2025 · Pharmacy
  41. On the location and the strength of controllers to desynchronize coupled Kuramoto oscillators
    Martin Moriamé, Timotéo Carletti · 2025 · Journal of Physics A Mathematical and Theoretical
  42. Orphan G Protein-Coupled Receptor GPR88: Mapping Its Significance in Central Nervous System Disorders
    Yanli Zhao, Dongxu Yue, Yingying Zou · 2025 · Molecular Neurobiology
  43. Prevalencia, características demográficas de la enfermedad de Parkinson y comorbilidades asociadas: un análisis del registro oficial del Ministerio de Salud de Colombia
    Gabriela Rincón, Camila Pantoja‐Ruiz, Juan Felipe Torres, Claudia Sofía Tamayo-Torres, Diego Rosselli · 2025 · Acta neurológica colombiana
  44. Development, characterisation and neuroprotective effects of polymer–drug conjugate nano-polyplex: working towards a multi-target treatment for neurodegenerative diseases
    Nuruddin Mahadik, Gemma Ann Barron, Paul Kong Thoo Lin, Colin J. Thompson · 2025 · Materials Advances
  45. Effects of tropicamide on catalepsy and motor function in a mouse model of Parkinson’s disease
    Érica de Moraes Santos Corrêa, Albert Schiaveto de Souza, Gustavo Christofoletti · 2025 · Aging advances.
  46. Neuropharmacological activities of Eclipta alba (L.) Hassk. in the context of Alzheimer's and Parkinson's diseases: A mini review
    Abir Biswas, R G Abirami, Anitha Rathinam, Kesavan Swaminathan Jayachandran, Muthuswamy Anusuyadevi · 2025 · Pharmacological Research - Natural Products
  47. Intersection of Autonomic Dysfunction and Parkinson’s Disease: Insights Into Neurogenic and Classical Orthostatic Hypotension
    Jamir Pitton Rissardo, Masoumeh Rashidi, Fatemeh Rashidi, Khalil I Hmedat, Ibrahim Khalil, Hania Moharam, Mallak Bahar, Ali Dway, Omesh Prathiraja, Ana Letícia Fornari Caprara et al. · 2025 · Cureus
  48. A Mobile App Supporting Exercise Adherence for People with Parkinson’s Disease
    Kristoffer Upsahl, Annette Vistven, Astrid Bergland · 2018 · Lecture notes in computer science
  49. Understanding Identity Negotiation of Parkinson’s Disease and Occupational Engagement Using Narrative Inquiry
    Elena Sheldrake, Colleen McGrath, Debbie Laliberte Rudman, Jeff Holmes · 2021 · Physical & Occupational Therapy In Geriatrics
  50. Representaciones tiempo-frecuencia basadas en sensores inerciales para caracterizar la marcha en la enfermedad de Parkinson
    Marlon E. Bedoya-Vargas, Juan Camilo Vásquez-Correa, Juan Rafael Orozco‐Arroyave · 2018 · TecnoLógicas
  51. Dopaminergic Centers Neurodegeneration Biochemical and radiologic approach
    Dan Iulian Cuciureanu, Roxana Mihaela Popescu, Tudor Cuciureanu · 2019 · Revista de Chimie
  52. Idosos com doença de parkinson: perfil e condições de saúder
    Rafaela de Carvalho Baptista, Ángela María Álvarez, Simony Fabíola Lopes Nunes, Rafaela Vivian Valcarenghi, Sayonara de Fátima Faria Barbosa · 2020 · Enfermagem em Foco
  53. Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson’s Disease
    Wenting Li, Yoshio Goshima, Toshio Ohshima · 2020 · Neurochemical Research
  54. Efectividad del trabajo de resistencia y de cicloergómetro a alta velocidad sobre la bradicinesia en la enfermedad de Parkinson: revisión sistemática
    F.M. Molina Palomino, L. López López, Janet Rodríguez‐Torres, Maria Granados Santiago, Araceli Ortíz‐Rubio, Irene Cabrera Martos, Maríe Carmen Valenza · 2021 · Fisioterapia
  55. Balance and Gait Disturbances and Quality of Life in Patients with Idiopathic Parkinson'S Disease and Progressive Supranuclear Palsy
    Hatice Eraslan Boz, Aycem Öztürk Kiriş, Koray Koçoğlu, Berril Dönmez Çolakoğlu, Raif Çakmur, Gülden Akdal · 2021 · Neurological Sciences and Neurophysiology
  56. Effects of medication and dual tasking on postural sway in Parkinson’s disease: A pilot case study
    Arito Yozu, Kohei Kaminishi, Daisuke Ishii · 2021 · Advanced Robotics
  57. Reverse Visually Guided Reaching in Patients with Parkinson’s Disease
    Pauline Gaprielian, Stephen Harold Scott, Ron Levy · 2022 · Parkinson s Disease
  58. The modulatory effect of 100 Hz electroacupuncture on striatal synaptic plasticity in unilateral lesioned 6-OHDA rats
    Min Li, Ke Wang, Wenting Su, Jun Jia, Xiaomin Wang · 2022 · Brain Research Bulletin
  59. A concise review of the orofacial mesenchymal stromal cells as a novel therapy for neurological diseases and injuries
    Zhili Dong, Liping Wu, Lu Zhao · 2022 · Journal of Tissue Engineering and Regenerative Medicine
  60. Neuroprotective effects of black cumin seed and seed oil
    Hakan Ak, İsmail Gülşen, İhsan Canbek · 2022 · Elsevier eBooks
  61. Dominant Attractor in Coupled Non-Identical Chaotic Systems
    Dorsa Nezhad Hajian, Sriram Parthasarathy, Fatemeh Parastesh · 2022 · Entropy
  62. Neurological complications in infection with the SARS-COV-2 virus: Parkinson’s disease and the impact on professional reintegration - case study
    Maria Valentina Popa, Nicoleta Luchian, Bogdan Gurzu · 2022 · Romanian Journal of Occupational Medicine
  63. Preservation of Dopamine Levels in a Mouse Model of Parkinson's Disease by Carboxymethylated Silica and Starch Nanoparticles Coupled to Silybin
    Esperanza Garcı́a, Luis Arturo García‐De‐La‐Rosa, Marı́a Fernanda Veloz Castillo, M.A. Mendéz-Rojas, Anahí Chavarría · 2023 · ChemistrySelect
  64. Recognition of Parkinson's disease and Parkinson's dementia based on gait analysis and machine learning
    Shuai Tao, Yi Wang, Huaying Cai · 2023 · International Symposium on Computer Engineering and Intelligent Communications (ISCEIC)
  65. Protective effects of cell permeable Tat-PIM2 protein on oxidative stress induced dopaminergic neuronal cell death
    Min Jea Shin, Won Sik Eum, Gi Soo Youn, Jung Hwan Park, Hyeon Ji Yeo, Eun Ji Yeo, Hyun Jung Kwon, Eun Jeong Sohn, Lee Re Lee, Na Yeon Kim et al. · 2023 · Heliyon
  66. Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease
    Vasilija Stopic, Stefanie Theresa Jost, Juan Carlos Baldermann, Jan Niklas Petry‐Schmelzer, Gereon R. Fink, Till A. Dembek, Haidar Salimi Dafsari, Josef Kessler, Michael T. Barbe, Anna Sauerbier · 2023 · Journal of Parkinson s Disease
  67. DFT, ADME studies and evaluation of the binding with HSA and MAO-B inhibitory potential of protoberberine alkaloids from Guatteria friesiana: theoretical insights of promising candidates for the treatment of Parkinson’s disease
    Victor Lima Tananta, Emmanoel Vilaça Costa, Yohannan Sheena Mary, Y. Shyma Mary, Jamelah Saleh Al-Otaibi, Renyer Alves Costa · 2023 · Journal of Molecular Modeling
  68. Is Lyapunov exponent a reliable metric to detect dynamic stability in Parkinson’s disease?
    Adriana Torres-Pardo, Jorge A. Gómez-García, Nicolás Eugenio Gómez Suárez, Adriana Muñoz-González, Miguel González-Sánchez, Francisco Grandas, Juan Camilo Moreno, Diego Torricelli · 2023 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  69. Exploring the Neuroprotective Effects of Nicotine Against MPTP-Induced Neuronal Damage in Mice: Insights into Antioxidant System
    Nikoloz Zhgenti, Otar Bibilashvili, George Burjanadze, Mariam Shengelia, Nana Koshoridze · 2023 · International Journal of Biochemistry and Biophysics
  70. Design of a stabilisation platform for Parkinson’s disease patient
    Luay Fraiwan, Safi Amir, Fahad Ahmed, Junaid Halepota · 2018 · Journal of Medical Engineering & Technology
  71. Can We Predict the Motor Performance of Patients With Parkinson's Disease Based on Their Symptomatology?
    Karina Lebel, Christian Duval, Étienne Goubault · 2020 · Frontiers in Bioengineering and Biotechnology
  72. Narcolepsy in Parkinson's disease with insulin resistance
    Alisha Chunduri, Wim E. Crusio, Anna Delprato · 2021 · F1000Research
  73. Relación entre kinesiofobia, capacidad al ejercicio y funcionalidad en pacientes con Parkinson y congelación de la marcha en ``On
    Javier Martín Núñez · 2021 · European journal of health research
  74. Impactos globais da infecção por COVID-19 em pacientes com a doença de Parkinson: uma revisão integrativa
    Karina Maia Paiva, Rodrigo Freire Oliveira, Gabriel S. Rocha, Paulo Leonardo Araújo de Góis Morais, Dayane Pessoa de Araújo, Lucídio Clebeson de Oliveira, Fausto Pierdoná Gúzen, José Rodolfo Lopes de Paiva Cavalcanti · 2021 · Research Society and Development
  75. DATA ANALYTICS FOR WEARABLE IOT-BASED TELEMEDICINE
    Rassoul Diouf · 2019
  76. Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach
    Meenakshi Ahluwalia, Pankaj Gaur, Kumar Vaibhav · 2023 · Biomedicines
  77. New tree shrew Parkinson’s model: a cost-effective alternative to monkey models
    Hao Li, Leyi Mei, Xiupeng Nie, Liping Wu, Xiaofeng Ren, Longbao Lv, Jitong Yang, Haonan Cao, Jing Wu, Yuhua Zhang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Single-cell Spatial Transcriptomics Reveals Disease-specific Microenvironmental Niches in Neurodegeneration and COVID-19
    Simon Graf, Nicole Ludwig, Matthias Flotho, Annika Engel, Ian Ferenc Diks, Paula Zimmer, Wiebke M. Wemheuer, Arne Wrede, Daniela Mîrzac, Gabriel González‐Escamilla et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Sex-dimorphic effects of neuromelanin buildup in rodent nigral dopamine neurons: implications for sex-biased vulnerability in Parkinson’s disease
    Sebastian Luca D’Addario, Mariangela Massaro Cenere, Francesca Cossa et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  80. The rationale of treatment strategies in Parkinsons disease in relation to motor and cognitive dysfunctions: a review
    Enas Kassem, Noha Barradah · 2021 · International Journal of Medicine in Developing Countries
  81. Research Progress of Collapse Response Mediator Proteins in Neurodegenerative Diseases
    Kun Qin, Shaoye Xu, Yu Han · 2022 · Developmental Neuroscience
  82. Sintomas de ansiedade e depressão em pessoas com doença de parkinson durante a pandemia de Covid-19
    Ana Caroline Pereira Matheus, Michelle Del Nery, Suelen Umbelino da Silva, Ana Claudia de Souza Fortaleza Marques, Daniela Mizusaki Iyomasa · 2023 · Brazilian Journal of Health Review
  83. Clinical characteristics and reaction to dopaminergic treatment of drug-naïve patients with Parkinson's disease in central China: A cross sectional study
    Weiqi Zeng, Yukai Wang, Ling Liu, Yi Wu, Yu Xu, Heng Zhai, Xiaoman Yang, Xuebing Cao, Yan Xu · 2023 · Heliyon
  84. Exploring the prescribing trends and factors affecting initial anti-parkinsonian drug selection in Korea: A nationwide population-based cohort study
    Minhee Ku, Nam Kyung Je · 2023 · Journal of Clinical Neuroscience
  85. Cogs in the autophagic machine—equipped to combat dementia-prone neurodegenerative diseases
    Sholto de Wet, Rensu P. Theart, Ben Loos · 2023 · Frontiers in Molecular Neuroscience
  86. Effect of repetitive transcranial magnetic stimulation combined with balance training on improving balance function in patients with Parkinson’s disease: A randomized controlled trial
    Jiaquan Liao, Bo Wu, Zhen Yang · 2024 · Physiotherapy Practice and Research
  87. Association of insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene (ACE) with Parkinson’s disease and factors risk in eastern Algeria: case–control study
    Horchi Meroua, Rayene Achou, Djoudi Brahim, Rania Laouar, Gharzouli Razika, Taghane Naima, Noureddine Abadi, Dalila Satta · 2024 · Egyptian Journal of Medical Human Genetics
  88. Effect of physiotherapy on gait and balance for patients with Parkinson's disease: a review article
    Ahmed Elshanawany, Moshera Hassan Darwish, Shimaa Mohamed Refaat · 2024 · Bulletin of Physical Therapy Research and Studies
  89. Empathy design method based on immersive interactive experiential spaces: A case study of Parkinson’s disease in China
    Xinyu Yang, Jianfang Guan, Dongjun Han, Xipei Ren · 2024 · The Design Journal
  90. A Coordinate Enhanced Local and Global Attention Network for Handwriting Detection of Parkinson’s Disease
    Xuesen Niu, Nana Wang, Yongcan Liu, Aite Zhao · 2023 · International Conference on Computer, Internet of Things and Smart City (CIoTSC)
  91. eQTL mapping in transgenic alpha-synuclein carrying Caenorhabditis elegans recombinant inbred lines
    Yuqing Huang, Yiru A. Wang, Lisa van Sluijs, Demi H. J. Vogels, Yuzhi Chen, Vivian I. P. Tegelbeckers, Steven Schoonderwoerd, Joost A. G. Riksen, Jan E. Kammenga, Simon Crawford Harvey et al. · 2024 · Human Molecular Genetics
  92. Muscle Network of Parkinson’s Gait: A 12-Month Longitudinal Analysis Before and After Deep Brain Stimulation Surgery
    Marco Ghislieri, Lorenzo Locoratolo, Fabrizio Sciscenti, Michele Lanotte, Laura Rizzi, Valentina Agostini · 2026 · IEEE Transactions on Neural Systems and Rehabilitation Engineering
  93. Cardiovascular disorders in Parkinson's disease
    V. V. Yudina, Olga N. Voskresenskaya · 2025 · Russian neurological Journal
  94. Microneedles-based technology as an innovative strategy for alleviating neurological disorders – Current progress and future perspectives
    Sathyaraj Weslen Vedakumari, Lokesh Prabakaran, Yovan Raja Pravin · 2025 · Journal of Drug Delivery Science and Technology
  95. A Comparative Analysis of Effects of Rehabilitation Services on Symptomatology of Parkinson’s Disease-An Umbrella Review of Systematic Reviews and Meta-Analyses
    Zobia Farooq, Rayan Aboakel, Rabeaa Sahar · 2025 · Neurology Letters
  96. Evaluating the Antiparkinsonian activity of Tamarix gallica extract in a reserpine-induced rat model of Parkinsonism: behavioral and neurochemical assessments
    Savankumar Chhatrola, Pravin Tirgar · 2025 · The Egyptian Journal of Neurosurgery : the official publication of the Egyptian Society of Neurological Surgeons/Egyptian journal of neurosurgery
  97. Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria
    Victoria Soto Linan, Marc Hébert, Martin Lévesque · 2025 · Journal of Parkinson s Disease
  98. Particle Swarm Optimization of CNN for Early Parkinson’s Disease Detection
    Sharvesh T Srinivasan, Shrivanshi Ganesh Pai, Basavaraj V. Hiremath · 2025 · International Conference on Bio Signals, Images, and Instrumentation (ICBSII)
  99. Modeling characteristics of neuronal firing in the thalamocortical network of connections in control and parkinsonian primates
    Carly Ferrell, Qile Jiang, Margaret Olivia Leu · 2025 · Journal of Computational Neuroscience
  100. Systematic review of electron transfer study in DNA relevant to Parkinson’s disease and scanning tunneling microscopy
    Muhammad Hanif Che Lah, Faruque Reza, Shaharum Shamsuddin · 2025 · PeerJ